glp 1 gut microbiota Implement enhanced artificial “enteroendocrine L cells” via oral administration for effective treatment of type 2 diabetes Implement enhanced artificial “enteroendocrine L

10.1016/j.phrs.2013.06.005 Summary Keywords GLP1, miRNA, diabetes, lipids, metabolism Citation Capuani B, Pacifici F, Della-Morte D and Lauro D (2018) Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs

Secondary Research Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research

-2.1% with placebo, with 64% vs

The retatrutide + MOTS-C stack guide covers the community schedule, evidence limits, and vial math without turning animal findings into human promises